SERINC2 and schizophrenia: Specifically, SERINC2 mRNA exhibited its highest expression levels in the substantia nigra, followed by the cerebellum (Figure 1), and the expression in the substantia nigra and cerebellar hemisphere was down-regulated and up-regulated, respectively, by risk alleles for substance dependence, schizophrenia, OCD, and autism (Table 3A).